Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Grant/Award of 1,881 CAVA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | CAVA GROUP, INC. (CAVA) | Grant/Award | 1,881 | n/a |
| Jun 4, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 89,312 | n/a |
| May 4, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 35,714 | n/a |
| Jun 24, 2025 | CAVA GROUP, INC. (CAVA) | Grant/Award | 1,767 | n/a |
| Jun 3, 2025 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 103,806 | n/a |
| May 13, 2025 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 36,810 | n/a |
| Jun 24, 2024 | CAVA GROUP, INC. (CAVA) | Grant/Award | 1,307 | n/a |
| May 13, 2024 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 44,906 | n/a |
| Apr 29, 2024 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 8,032 | n/a |
| Nov 21, 2023 | CAVA GROUP, INC. (CAVA) | Purchase | 10,000 | $331.8K |